Thinking Ahead with TÜV SÜD Podcast

BIOCOMPATIBILITY TESTING STRATEGY: AN OVERVIEW OF RISK ASSESSMENT BASED TESTING STRATEGY

Powering the Future with TÜV SÜD: Episode #8

Powering the Future with TÜV SÜD: Episode #8

Powering the future V-Blog

Listen on: Apple Podcasts | Google Podcasts | Spotify

ABOUT THIS EPISODE

ISO 10993 is a series of standards for evaluating the biocompatibility of medical devices to manage biological risk. ISO 10993-17, ISO/TS 21726 specifically discusses the determination of allowable limits for substances leachable from medical devices based on a toxicological risk assessment of medical device constituents.
In this podcast, the speaker Dr. Shailendra Singh, shares key insights with regards to ISO 10993-1 Biological evaluation of medical devices. Dr. Singh holds an extensive experience in the field of Toxicology Research, Regulatory Affairs, Quality Assurance and Business Development.


EU MDR PODCAST OVERVIEW

  • 01 min 20 sec - Challenges in the traditional approach
  • 01 min 57sec -The important parameters of Biocompatibility evaluation
  • 05 min 52 sec -The Revised Testing Strategy
  • 12 min 47 sec -The important assessment that needs to be considered for Human Exposure Assessment
  • 14 min 43 sec -The Advantages of Risk-based Testing Strategy

RELATED LINKS

For more information about our Biocompatibility and Toxicological Risk Assessment of Medical Devices: The Notified Body Perspective training program, visit Biocompatibility and Toxicological Risk Assessment of Medical Devices: The Notified Body Perspective

 

Explore more podcast episodes

Thinking Ahead with TUV SUD Podcast
Podcast

KEY INSIGHTS ON EU MDR RECENT AMENDMENTS AND THEIR IMPLICATIONS

Powering the future with TÜV SÜD Podcast Ep.7

Listen Now

View all episodes

Next Steps

Site Selector